参考文献/References:
[1] Hindricks G,Potpara T,Dagres N,et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC[J]. Eur Heart J,2021,42(5):373-498.
[2] Aliot E,Botto GL,Crijns HJ,et al. Quality of life in patients with atrial fibrillation:how to assess it and how to improve it[J]. Europace,2014,16(6):787-796.
[3] Serpytis R,Navickaite A,Serpytiene E,et al. Impact of atrial fibrillation on cognitive function,psychological distress,quality of life,and impulsiveness[J]. Am J Med,2018,131(6):703.e1-703.e5.
[4] Blum S,Muff C,Aeschbacher S,et al. Prospective assessment of sex‐related differences in symptom status and health perception among patients with atrial fibrillation[J]. J Am Heart Assoc ,2017,6(7):e005401.
[5] Lip GY,Fauchier L,Freedman SB,et al. Atrial fibrillation[J]. Nat Rev Dis Primers,2016,2:16016.
[6] Randolph TC,Simon DN,Thomas L,et al. Patient factors associated with quality of life in atrial fibrillation[J]. Am Heart J,2016,182:135-143.
[7] Bostrom JA,Saczynski JS,Hajduk A,et al. Burden of psychosocial and cognitive impairment in patients with atrial fibrillation[J]. Crit Pathw Cardiol,2017,16(2):71-75.
[8] Jeong HK,Cho JG,Lee KH,et al. Determinants of quality of life in patients with atrial fibrillation[J]. Int J Cardiol,2014,172(2):e300-e302.
[9] Jankowska-Polańska B,Kaczan A,Lomper K,et al. Symptoms,acceptance of illness and health-related quality of life in patients with atrial fibrillation[J]. Eur J Cardiovasc Nurs,2018,17(3):262-272.
[10] Boveda S,Metzner A,Nguyen DQ,et al. Single-procedure outcomes and quality-of-life improvement 12 months post-cryoballoon ablation in persistent atrial fibrillation:results from the multicenter CRYO4PERSISTENT AF trial[J]. JACC Clin Electrophysiol,2018,4(11):1440-1447.
[11] Jain SK,Novak PG,Sangrigoli R,et al. Sustained quality-of-life improvement post-cryoballoon ablation in patients with paroxysmal atrial fibrillation:results from the STOP-AF Post-Approval Study[J]. Heart Rhythm,2020,17(3):485-491.
[12] Fichtner S,Deisenhofer I,Kindsm?ller S,et al. Prospective assessment of short- and long-term quality of life after ablation for atrial fibrillation [J]. J Cardiovasc Electrophysiol,2012,23(2):121-127.
[13] Fiala M,Wichterle D,Bulkova V,et al. A prospective evaluation of haemodynamics,functional status,and quality of life after radiofrequency catheter ablation of long-standing persistent atrial fibrillation[J]. Europace,2014,16(1):15-25.
[14] Katayama H,Shibata A,Doi A,et al. Successful catheter ablation improves exercise tolerance in persistent atrial fibrillation patients,especially those with reduced ventricular contraction,preserved atrial function,or a high CHADS2 score[J]. J Cardiol,2020,75(5):529-536.
[15] Sohns C,Zintl K,Zhao Y,et al. Impact of left ventricular function and heart failure symptoms on outcomes post ablation of atrial fibrillation in heart failure:CASTLE-AF Trial[J]. Circ Arrhythm Electrophysiol,2020,13(10):e008461.
[16] Hunter RJ,Berriman TJ,Diab I,et al. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial)[J]. Circ Arrhythm Electrophysiol,2014,7(1):31-38.
[17] Fiala M,Bulkova V,Sknouril L,et al. Functional improvement after successful catheter ablation for long-standing persistent atrial fibrillation[J]. Europace,2017,19(11):1781-1789.
[18] 邱琛茗,宋宝梅,董胤佳,等. 射频消融改善阵发性和长期持续性心房颤动患者生活质量的研究[J]. 现代生物医学进展,2019,19(23):4574-4577.
[19] Kuck KH,Fürnkranz A,Chun KR,et al. Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation:reintervention,rehospitalization,and quality-of-life outcomes in the FIRE AND ICE trial[J]. Eur Heart J,2016,37(38):2858-2865.
[20] Witassek F,Springer A,Adam L,et al. Health-related quality of life in patients with atrial fibrillation:the role of symptoms,comorbidities,and the type of atrial fibrillation[J]. PLoS One,2019,14(12):e0226730.
[21] Peinado R,Arribas F,Ormaetxe JM,et al. Variation in quality of life with type of atrial fibrillation[J]. Rev Esp Cardiol,2010,63(12):1402-1409.
[22] Kato M,Miake J,Ogura K,et al. Different effects of pulmonary vein isolation on quality of life between patients with persistent and paroxysmal atrial fibrillation[J]. Int Heart J,2019,60(6):1328-1333.
[23] Inagaki D,Fukamizu S,Tokioka S,et al. Quality of life improvements by durable pulmonary vein isolation in patients with atrial fibrillation[J]. J Cardiovasc Electrophysiol,2020,31(8):2013-2021.
[24] Wo?niak-Skowerska IM,Skowerski MJ,Hoffmann A,et al. Quality of life in patients with paroxysmal atrial fibrillation after circumferential pulmonary vein ablation[J]. Kardiol Pol,2016,74(3):244-250.
[25] Bertaglia E,Senatore G,de Michieli L,et al. Twelve-year follow-up of catheter ablation for atrial fibrillation:A prospective,multicenter,randomized study[J]. Heart Rhythm,2017,14(4):486-492.
[26] Mont L,Bisbal F,Hernández-Madrid A,et al. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation:a multicentre,randomized,controlled trial (SARA study)[J]. Eur Heart J,2014,35(8):501-507.
[27] Morillo CA,Verma A,Connolly SJ,et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2):a randomized trial[J]. JAMA,2014,311(7):692-700.
[28] Kuck KH,Merkely B,Zahn R,et al. Catheter ablation versus best medical therapy in patients with persistent atrial fibrillation and congestive heart failure:the randomized AMICA trial[J]. Circ Arrhythm Electrophysiol,2019,12(12):e007731.
[29] Geng J,Zhang Y,Wang Y,et al. Catheter ablation versus rate control in patients with atrial fibrillation and heart failure:a multicenter study[J]. Medicine (Baltimore),2017,96(49):e9179.
[30] Marrouche NF,Brachmann J,Andresen D,et al. Catheter ablation for atrial fibrillation with heart failure[J].N Engl J Med,2018,378(5):417-427.
[31] Mark DB,Anstrom KJ,Sheng S,et al. Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation:the CABANA randomized clinical trial[J]. JAMA,2019,321(13):1275-1285.
[32] Blomstr?m-Lundqvist C,Gizurarson S,Schwieler J,et al. Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation:the CAPTAF randomized clinical trial[J]. JAMA,2019,321(11):1059-1068.
[33] Adiyaman A,Buist TJ,Beukema RJ,et al. Randomized controlled trial of surgical versus catheter ablation for paroxysmal and early persistent atrial fibrillation[J]. Circ Arrhythm Electrophysiol,2018,11(10):e006182.
[34] Buist TJ,Adiyaman A,Beukema RJ,et al. Quality of life after catheter and minimally invasive surgical ablation of paroxysmal and early persistent atrial fibrillation:results from the SCALAF trial[J]. Clin Res Cardiol,2019,109(2):215-224.
[35] Haldar S,Khan HR,Boyalla V,et al. Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation:CASA-AF randomized controlled trial[J]. Eur Heart J,2020,41(47):4471-4480.
[36] Genev IK,Tompkins LA,Khare MM,et al. Comparison of the efficancy and complication rates of the hybrid maze,complete Cox-maze and catheter ablation in the treatment of atrial fibrillation[J]. J Atr Fibrillation,2017,9(5):1543.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(10):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(10):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(10):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(10):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(10):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(10):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(10):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(10):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(10):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(10):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
[11]吴彤 高东来.心房颤动合并心力衰竭的射频消融治疗[J].心血管病学进展,2019,(5):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
WU TongGAO Donglai.Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2019,(10):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
[12]赵磊 梁兆光.导管消融术后心房颤动复发的危险因素及预防[J].心血管病学进展,2019,(5):766.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.025]
ZHAO LeiLIANG Zhaoguang.Risk Factors and Prevention of Atrial Fibrillation Recurrence after Catheterablation[J].Advances in Cardiovascular Diseases,2019,(10):766.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.025]
[13]辛小宇 梁兆光.心房颤动导管消融围术期抗凝治疗研究进展[J].心血管病学进展,2020,(8):809.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.007]
XIN XiaoyuLIANG Zhaoguang.Perioperative Anticoagulation for Atrial Fibrillation Catheter Ablation[J].Advances in Cardiovascular Diseases,2020,(10):809.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.007]
[14]赵灿 吴永全.基于环肺静脉隔离的房颤导管消融策略选择治疗进展[J].心血管病学进展,2020,(12):1234.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.003]
ZHAO Can,WU Yongquan.Catheter Ablation Strategies for Atrial Fibrillation Based on Circumferential Pulmonary Vein Isolation[J].Advances in Cardiovascular Diseases,2020,(10):1234.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.003]
[15]刘玉辉 王盼盼 陈椿.心房颤动性心肌病临床研究进展[J].心血管病学进展,2020,(12):1238.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.004]
LIU Yuhui,WANG Panpan,CHEN Chun.Atrial Fibrillation-induced Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(10):1238.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.004]
[16]白金龙 李洪仕 蔡衡.非瓣膜性心房颤动导管消融术后抗凝策略的研究进展[J].心血管病学进展,2021,(1):30.[doi:10.16806/j.cnki.issn.1004-3934.201.01.000]
[17]那丞 黄织春.干预自主神经对心房颤动影响的研究进展[J].心血管病学进展,2021,(1):30.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
NA Cheng,HUANG Zhichun.Effect of Autonomic Nerve Intervention on Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2021,(10):30.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
[18]徐尧 蔡衡 李洪仕.心房颤动合并心力衰竭的导管消融治疗[J].心血管病学进展,2021,(4):322.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.009]
XU Yao,CAI Heng,LI Hongshi.Role of Radiofrequency Ablation in Patients with Atrial Fibrillation and Heart Failure[J].Advances in Cardiovascular Diseases,2021,(10):322.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.009]
[19]邹永伟 胡小恋.左房低电压与心房颤动相关性的研究进展[J].心血管病学进展,2022,(3):211.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
ZHOU Yongwei,H U Xiaolian.The Correlation Between Left Atrial Low-Voltage Area and Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2022,(10):211.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[20]李珂 赵海娟 赵耀 黄松群 郭志福.肥厚型心肌病合并心房颤动的导管消融[J].心血管病学进展,2022,(5):399.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.004]
LI Ke,ZHAO Haijuan,ZHAO Yao,et al.Catheter Ablation of Hypertrophic Cardiomyopathy with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2022,(10):399.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.004]